Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 11, 2021
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharmaceuticals Inc
| -8.57K |
$2.88 | -$24,660.74 | -42.23% | 11.72K |
Mar 17 - May 17
| |||||||
Cumberland Pharmaceuticals Inc
| 366 |
$3.55 | $1,366.98 | +1.84% | 20.29K |
Mar 18 - Mar 23
| |||||||
Cumberland Pharmaceuticals Inc
| 3.53K |
$5.87 | $20,755.46 | +19.14% | 19.92K |
Mar 22
| |||||||
Cumberland Pharmaceuticals Inc
| 400 |
$6.00 | $2,400.00 | +2.22% | 18.45K |
Aug 28 - Aug 29
| |||||||
Cumberland Pharmaceuticals Inc
| 400 |
$6.12 | $2,448.00 | +2.27% | 18.05K |
May 17
| |||||||
Cumberland Pharmaceuticals Inc
| 1.96K |
$6.70 | $13,117.90 | +12.47% | 17.65K |
Mar 19 - Mar 23
| |||||||
Cumberland Pharmaceuticals Inc
| 250 |
$7.81 | $1,952.50 | +1.62% | 15.7K |
Nov 22
| |||||||
Cumberland Pharmaceuticals Inc
| 500 |
$6.72 | $3,360.00 | +3.35% | 15.45K |
Aug 23
| |||||||
Cumberland Pharmaceuticals Inc
| 300 |
$6.95 | $2,085.00 | +2.05% | 14.95K |
May 31
| |||||||
Cumberland Pharmaceuticals Inc
| 1.85K |
$6.45 | $11,913.15 | +14.43% | 14.65K |
Apr 7
| |||||||
Cumberland Pharmaceuticals Inc
| 900 |
$6.42 | $5,778.00 | +7.56% | 12.8K |
Mar 23
| |||||||
Cumberland Pharmaceuticals Inc
| 900 |
$5.50 | $4,950.00 | +8.18% | 11.9K |
Nov 17
| |||||||
Cumberland Pharmaceuticals Inc
| 5K |
$4.34 | $21,700.00 | +83.33% | 11K |
Apr 6
| |||||||
Cumberland Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||